FALZARANO, Maria Sofia
 Distribuzione geografica
Continente #
NA - Nord America 7.328
AS - Asia 3.888
EU - Europa 3.092
SA - Sud America 688
AF - Africa 94
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.152
Nazione #
US - Stati Uniti d'America 7.101
SG - Singapore 1.463
CN - Cina 937
PL - Polonia 767
IT - Italia 680
BR - Brasile 554
VN - Vietnam 430
DE - Germania 428
HK - Hong Kong 302
UA - Ucraina 268
GB - Regno Unito 257
TR - Turchia 201
FI - Finlandia 127
FR - Francia 127
CA - Canada 116
JP - Giappone 109
RU - Federazione Russa 104
BD - Bangladesh 103
IN - India 100
SE - Svezia 100
MX - Messico 78
ID - Indonesia 62
AR - Argentina 54
NL - Olanda 52
AU - Australia 46
ZA - Sudafrica 40
BE - Belgio 39
ES - Italia 37
PK - Pakistan 31
IQ - Iraq 30
CO - Colombia 21
CZ - Repubblica Ceca 19
LT - Lituania 17
MA - Marocco 17
CL - Cile 15
VE - Venezuela 15
PH - Filippine 14
NZ - Nuova Zelanda 13
MY - Malesia 11
RO - Romania 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
EC - Ecuador 10
SA - Arabia Saudita 10
AT - Austria 9
IE - Irlanda 9
TH - Thailandia 9
EG - Egitto 7
KE - Kenya 7
BO - Bolivia 6
CR - Costa Rica 6
JO - Giordania 6
KR - Corea 6
NP - Nepal 6
PE - Perù 6
IL - Israele 5
JM - Giamaica 5
PT - Portogallo 5
TN - Tunisia 5
AZ - Azerbaigian 4
EE - Estonia 4
KZ - Kazakistan 4
LB - Libano 4
QA - Qatar 4
BG - Bulgaria 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
NG - Nigeria 3
PA - Panama 3
PY - Paraguay 3
RS - Serbia 3
SV - El Salvador 3
UY - Uruguay 3
AO - Angola 2
BB - Barbados 2
ET - Etiopia 2
GD - Grenada 2
GT - Guatemala 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
Totale 15.132
Città #
Singapore 895
Ashburn 890
Warsaw 764
Fairfield 605
Woodbridge 517
San Jose 446
Houston 363
Ann Arbor 360
Chandler 355
Beijing 343
Santa Clara 300
Jacksonville 289
Hong Kong 287
Seattle 233
Wilmington 219
Cambridge 180
New York 158
Los Angeles 148
Dallas 146
Ho Chi Minh City 120
Munich 106
Hanoi 103
Izmir 98
Milan 91
Nanjing 91
Tokyo 91
Ferrara 81
Princeton 74
Boardman 65
Lauterbourg 62
Shanghai 59
São Paulo 58
Council Bluffs 54
Orem 53
San Diego 52
Rome 50
Mexico City 46
Brescia 45
Dong Ket 44
Bremen 43
Helsinki 40
London 40
Montreal 40
Brussels 39
Jakarta 39
Buffalo 38
Brooklyn 33
Johannesburg 33
Addison 31
Toronto 31
Turku 31
Chennai 29
Chicago 29
Denver 29
Hefei 29
Stockholm 29
Tianjin 29
Phoenix 28
The Dalles 28
Sydney 25
Atlanta 24
Frankfurt am Main 24
Poplar 23
Shenyang 22
Nanchang 21
Boston 20
Changsha 20
Da Nang 19
Jinan 19
Bologna 18
Moscow 18
Hebei 17
Naples 16
Brno 15
Dearborn 15
Jiaxing 15
Haiphong 14
Charlotte 13
Mumbai 13
Nuremberg 13
Auburn Hills 12
Florence 12
Manchester 12
Norwalk 12
Perth 12
Rio de Janeiro 12
San Francisco 12
Amsterdam 11
Brasília 11
Falls Church 11
Querétaro 11
Wan Chai 11
Zhengzhou 11
Ankara 10
Baghdad 10
Biên Hòa 10
Curitiba 10
Hamilton 10
Miami 10
Redwood City 10
Totale 10.213
Nome #
Duchenne muscular dystrophy: From diagnosis to therapy 562
Meccanismi del danno neuronale indotto dalla tossina mitocondriale sodio azide in colture primarie di corteccia di ratto. Effetti sulle Protein Kinasi C. 499
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 475
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 411
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 360
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease 319
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 313
Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype 284
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures 275
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 273
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 269
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 264
Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the Literature 261
Characterization of a rare case of Ullrich congenital muscular dystrophy due to truncating mutations within the COL6A1 gene C-terminal domain: a case report 252
Exon skipping-mediated dystrophin reading frame restoration for small mutations 242
Sodium Azide Induced Neuronal Damage In Vitro: Evidence for Non-Apoptotic Cell Death 234
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 233
Spatial RNA-mapping reveals the unique patterns of expression and localisation of dystrophin isoforms in the human adult normal brain to improve understanding of brain involvement in muscular dystrophy 224
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 224
Biodistribution and Molecular Studies on Orally Administered Nanoparticle-AON Complexes Encapsulated with Alginate Aiming at Inducing Dystrophin Rescue in mdx Mice 221
Sodium azide: a useful tool for in vitro studying neurodegenerative diseases. 220
Biodistribution Studies of Polymeric Nanoparticles for Drug Delivery in Mice. 215
Homozygous Recessive Versican Missense Variation Is Associated With Early Teeth Loss in a Pakistani Family 214
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 209
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 209
Differential activation of protein kinase C isoforms following chemical ischemia in rat cerebral cortex slices 206
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 195
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 191
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing 189
Physical and transcriptional characterization of human urinary stem cell populations 187
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 186
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 185
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 185
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 182
Protective effect of a peptide derived from the endogenous PKC inhibitor PKI55 on the neurosecretory function in ischemic brain slices 181
RNAseq in urine-derived stem cells identified the expression of 308 neuromuscular gene transcripts [NEXT GENERATION SEQUENCING AND EXPERIMENTAL MYOLOGY: P.384] 181
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 176
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 176
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 175
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 174
null 172
Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for duchenne muscular dystrophy. 172
Oligomeric formylpeptide activity on human neutrophils 169
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 168
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 166
activation of signal transduction pathway leading to chemotaxis human neutrophils by a pure chemoattractant 166
2-phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrozole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis 166
Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy 166
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 166
MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping 165
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 163
Protein kinase C isoforms changes induced by chemical ischemia-reperfusion in rat cerebral cortex slices 161
P1.19 Whole genetic and protein characterisation in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing 158
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 157
Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of DUX4 157
mRNA in situ hybridization exhibits unbalanced nuclear/cytoplasmic dystrophin transcript repartition in Duchenne myogenic cells and skeletal muscle biopsies 153
A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis 151
Nanodiagnostics and nanodelivery applications in genetic alterations 151
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 143
Nanoparticles to deliver antisense oligonucleotides aimed at exon skipping therapies 141
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice 139
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 120
Effects of chemical ischemia on cerebral cortex slices: focus on mitogen-activated protein kinase cascade. 119
Urine-Derived Stem Cells Express 571 Neuromuscular Disorders Causing Genes, Making Them a Potential in vitro Model for Rare Genetic Diseases 119
null 113
New-pyrazolyl-ureas as potent human neutrophil chemotaxis inhibitors 111
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 110
Synthetic formyl tripeptide chemoattractants: a C-alpha,C-alpha-dialkylated, amphiphilic glycyl residue at position 1 110
Effects of PKI55 protein, an endogenous protein kinase C modulator, on specific PKC isoforms activity and on human T cells proliferation 108
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 106
Formylpeptides trigger selective molecular pathways that are required in the physiological functions of human neutrophils. 99
null 96
null 94
new pyrazolyl ureas as potent human neutrophil chemotaxis inhibitors 93
null 92
null 92
null 90
null 87
null 80
Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils 75
Totale 15.295
Categoria #
all - tutte 60.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 754
Totale 61.354


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202188 0 0 0 0 0 0 0 0 0 0 0 88
2021/2022840 31 101 58 27 28 26 62 45 33 53 124 252
2022/2023853 79 80 25 112 165 110 48 58 80 15 53 28
2023/2024582 44 45 40 16 27 104 31 52 22 18 13 170
2024/20252.198 47 36 161 115 263 227 130 108 350 258 264 239
2025/20265.878 624 267 496 829 970 370 649 270 427 571 318 87
Totale 15.295